Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis Source: Eur Respir J 2001; 17: 64-70 Year: 2001
Differences in responsiveness of airways to AMP and methacholine in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 93s Year: 2001
The bronchoprotective effects of levocetirizine on adenosine monophosphate challenge in patients with atopic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004
Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine Source: Eur Respir J 2002; 19: 611-616 Year: 2002
Direct and indirect bronchial challenge tests with Methacholine and Adenosine monophosphate in asthmatic patients and healthy subjects Source: Annual Congress 2010 - Advances in lung function II Year: 2010
Airway hyperresponsiveness accessed by adenosine monophosphate bronchial provocation test Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
Different associations of inflammation and current smoking with bronchial hyperresponsiveness (BHR) to histamine and BHR to AMP in families with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 410s Year: 2002
Measuring airway responsiveness in infants to AMP Source: Eur Respir J 2002; 20: Suppl. 38, 413s Year: 2002
PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
Cellular and gas exchange responses to adenosine 5‘-monophosphate (AMP) challenge in mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
The adenosine A2A -Receptor is not involved in adenosine induced bronchoconstriction in asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 103s Year: 2003
Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011
Ciclesonide decreases exhaled breath nitric oxide and rapidly reduces airway responsiveness to adenosine monophosphate in asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 252s Year: 2005
Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP) Source: International Congress 2017 – Monitoring asthma control Year: 2017
Dissimilarity between seasonal changes in airway responsiveness to adenosine-5'-monophosphate and methacholine in patients with grass pollen allergic rhinitis: relation to induced sputum Source: Annual Congress 2003 - Clinical allergen and adenosine provocation to understand asthma Year: 2003
Bronchial hyperresponsiveness to adenosine 5‘-monophosphate and methacoline: a comparison trial Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Association between inflammation of the airways and airway hyperresponsiveness to indirect bronchoprovocation – a population study Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008
Effects of salbutamol on gas exchange abnormalities and sputum neutrophilia induced by adenosine 5‘-monophosphate (AMP) in mild asthma Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006
Effect of budesonide on AMP and methacholine airway responsiveness and sputum cellularity: a time-course study Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001